277 related articles for article (PubMed ID: 7817812)
1. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
2. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
[TBL] [Abstract][Full Text] [Related]
3. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
4. [Urinary excretion of free and total deoxypyridinoline during secondary hyperparathyroidism in the elderly. Comparison of chromatographic (HPLC) and immunoenzymatic (Pyrilinks-D) methods].
Meddah B; Brazier M; Kamel S; Maamer M; Samson L; Desmet G; Sebert JL
Ann Biol Clin (Paris); 1996; 54(10-11):353-8. PubMed ID: 9092303
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
6. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
7. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
[TBL] [Abstract][Full Text] [Related]
8. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
[TBL] [Abstract][Full Text] [Related]
10. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
11. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease.
Delmas PD; Gineyts E; Bertholin A; Garnero P; Marchand F
J Bone Miner Res; 1993 May; 8(5):643-8. PubMed ID: 8511992
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
[TBL] [Abstract][Full Text] [Related]
13. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
[TBL] [Abstract][Full Text] [Related]
14. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
15. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
Asaba Y; Hiramatsu K; Matsui Y; Harada A; Nimura Y; Katagiri N; Kobayashi T; Takewaka T; Ito M; Niida S; Ikeda K
Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925
[TBL] [Abstract][Full Text] [Related]
16. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
Wilkinson JM; Jackson B; Eastell R
Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
[TBL] [Abstract][Full Text] [Related]
17. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
18. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
19. Reference value for urinary deoxypyridinoline as a specific marker for measuring bone resorption in Thais.
Pidetcha P; Intramanee S; Patrakarn K; Leelahakul P; Fongsupa S
J Med Assoc Thai; 1999 Nov; 82(11):1136-41. PubMed ID: 10659549
[TBL] [Abstract][Full Text] [Related]
20. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
Garnero P; Gineyts E; Arbault P; Christiansen C; Delmas PD
J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
